Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Novavax Inc Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $122 Billion
- Q2 2025
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Novavax Inc stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 30,739 shares of NVAX stock, worth $270,195. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,739
Previous 33,169
7.33%
Holding current value
$270,195
Previous $212,000
8.96%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding NVAX
# of Institutions
312Shares Held
94.4MCall Options Held
6.11MPut Options Held
10.5M-
Vanguard Group Inc Valley Forge, PA15.4MShares$136 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$104 Million0.0% of portfolio
-
Shah Capital Management11.5MShares$101 Million35.13% of portfolio
-
State Street Corp Boston, MA6.82MShares$60 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.94MShares$34.6 Million0.02% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $688M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...